AKLI
Price:
$0.4331
Market Cap:
$34.10M
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.[Read more]
Industry
Medical - Healthcare Information Services
IPO Date
2021-06-30
Stock Exchange
NASDAQ
Ticker
AKLI
According to Akili, Inc.’s latest financial reports and current stock price. The company's current ROE is -74.46%. This represents a change of 293.74% compared to the average of -18.91% of the last 4 quarters.
The mean historical ROE of Akili, Inc. over the last ten years is -30.66%. The current -74.46% ROE has changed 142.81% with respect to the historical average. Over the past ten years (40 quarters), AKLI's ROE was at its highest in in the September 2022 quarter at 106.14%. The ROE was at its lowest in in the December 2021 quarter at -29.82%.
Average
-30.66%
Median
-7.20%
Minimum
-101.64%
Maximum
25.09%
Discovering the peaks and valleys of Akili, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.31%
Maximum Annual ROE = 25.09%
Minimum Annual Increase = -484.58%
Minimum Annual ROE = -101.64%
Year | ROE | Change |
---|---|---|
2023 | -101.64% | 1.31% |
2022 | -7.20% | -92.35% |
2021 | -94.02% | -484.58% |
2020 | 24.45% | -2.55% |
The current ROE of Akili, Inc. (AKLI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-67.62%
5-year avg
-30.66%
10-year avg
-30.66%
Akili, Inc.’s ROE is less than EUDA Health Holdings Limited (0%), less than FOXO Technologies Inc. (182.22%), less than Aclarion, Inc. (60.45%), greater than Augmedix, Inc. (-422.89%), greater than ETAO International Co., Ltd. (-182.36%), greater than Computer Programs and Systems, Inc. (-1369.49%), greater than National Research Corporation (-32.86%), less than Forian Inc. (67.40%), greater than HealthEquity, Inc. (-9.81%), less than Health Catalyst, Inc. (4.60%), greater than Streamline Health Solutions, Inc. (-22.04%), greater than HealthStream, Inc. (-71.11%), less than NextGen Healthcare, Inc. (5.67%), less than null (2.69%),
Company | ROE | Market cap |
---|---|---|
0% | $171.63M | |
182.22% | $4.74M | |
60.45% | $1.35M | |
-422.89% | $115.91M | |
-182.36% | $9.78M | |
-1369.49% | $133.71M | |
-32.86% | $406.60M | |
67.40% | $62.65M | |
-9.81% | $8.31B | |
4.60% | $426.24M | |
-22.04% | $14.23M | |
-71.11% | $951.83M | |
5.67% | $1.61B | |
2.69% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Akili, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Akili, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Akili, Inc.'s ROE?
How is the ROE calculated for Akili, Inc. (AKLI)?
What is the highest ROE for Akili, Inc. (AKLI)?
What is the 3-year average ROE for Akili, Inc. (AKLI)?
What is the 5-year average ROE for Akili, Inc. (AKLI)?
How does the current ROE for Akili, Inc. (AKLI) compare to its historical average?